HHC
MYOK

Hutchin Hill Capital’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Hutchin Hill Capital’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-31,300
Closed -$410K – 1052
2017
Q2 		$410K Buy
31,300
+19,400
+163% +$256K 0.01% 708
2017
Q1 		$156K Buy
+11,900
New +$152K ﹤0.01% 865

Other funds holding MYOK

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Hutchin Hill Capital's MYOK Position: Q3 2017 in Review

Hutchin Hill Capital sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2017, closing a stake of 31,300 shares — an estimated $410K sold.

Hutchin Hill Capital first reported a position in MYOK in Q1 2017 and held it in 2 quarters. The position peaked at $410K in Q2 2017. 115 funds tracked by Wall St. Rank hold MYOK as of Q3 2017.

  • Hutchin Hill Capital reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • Hutchin Hill Capital sold 31,300 MyoKardia, Inc. Common Stock shares in Q3 2017, an estimated $410K.
  • Hutchin Hill Capital first reported a position in MyoKardia, Inc. Common Stock in Q1 2017 and held it in 2 quarters.
  • Hutchin Hill Capital's MyoKardia, Inc. Common Stock position peaked at $410K in Q2 2017.
  • 115 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2017.

Based on Hutchin Hill Capital's 13F filing for Q3 2017, filed 14 Nov 2017.